Centric Wealth Management Eli Lilly & CO Transaction History

Centric Wealth Management

$383 Million
Q3 2024

A detailed history of Centric Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Centric Wealth Management holds 13,556 shares of LLY stock, worth $10.7 Million. This represents 3.14% of its overall portfolio holdings.

Number of Shares

13,556

Previous 13,737 1.32%

Holding current value

$10.7 Million

Previous $12.4 Million 3.44%

% of portfolio

3.14%

Previous 3.78%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $139,757 - $173,763	-181 Reduced 1.32%	13,556 $12 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $280,524 - $351,798	-387 Reduced 2.74%	13,737 $12.4 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $347,621 - $465,068	587 Added 4.34%	14,124 $11 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $81,929 - $96,584	156 Added 1.17%	13,537 $7.89 Million
Q3 2023 Nov 03, 2023	SELL	$434.7 - $599.3 $369,060 - $508,805	-849 Reduced 5.97%	13,381 $7.19 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $44,894 - $60,029	128 Added 0.91%	14,230 $6.67 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $65,232 - $76,612	210 Added 1.51%	14,102 $4.84 Million
Q4 2022 Jan 04, 2023	BUY	$321.55 - $374.67 $39,872 - $46,459	124 Added 0.9%	13,892 $0
Q3 2022 Oct 05, 2022	SELL	$296.48 - $337.87 $625,572 - $712,905	-2,110 Reduced 13.29%	13,768 $4.45 Million
Q2 2022 Jul 06, 2022	SELL	$278.73 - $327.27 $932,630 - $1.1 Million	-3,346 Reduced 17.41%	15,878 $5.15 Million
Q1 2022 Apr 05, 2022	SELL	$234.69 - $291.66 $49,754 - $61,831	-212 Reduced 1.09%	19,224 $5.51 Million
Q4 2021 Jan 27, 2022	BUY	$224.85 - $279.04 $34,177 - $42,414	152 Added 0.79%	19,436 $5.37 Million
Q3 2021 Oct 06, 2021	SELL	$221.6 - $272.71 $1,108 - $1,363	-5 Reduced 0.03%	19,284 $4.46 Million
Q2 2021 Jul 21, 2021	SELL	$180.55 - $233.54 $105,802 - $136,854	-586 Reduced 2.95%	19,289 $4.43 Million
Q1 2021 Apr 14, 2021	SELL	$164.32 - $212.72 $74,601 - $96,574	-454 Reduced 2.23%	19,875 $3.71 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $725,357 - $959,822	5,560 Added 37.65%	20,329 $3.43 Million
Q3 2020 Oct 05, 2020	SELL	$146.22 - $169.13 $103,377 - $119,574	-707 Reduced 4.57%	14,769 $1.58 Million
Q2 2020 Jul 29, 2020	BUY	$136.42 - $164.18 $96,448 - $116,075	707 Added 4.79%	15,476 $2.54 Million
Q1 2020 Apr 08, 2020	SELL	$119.05 - $147.35 $7,976 - $9,872	-67 Reduced 0.45%	14,769 $1.58 Million
Q4 2019 Jan 06, 2020	BUY	$106.92 - $132.43 $7,163 - $8,872	67 Added 0.45%	14,836 $1.95 Million
Q3 2019 Oct 03, 2019	BUY	$106.79 - $116.16 $117,896 - $128,240	1,104 Added 8.08%	14,769 $1.58 Million
Q2 2019 Jul 08, 2019	SELL	$110.79 - $129.32 $12,297 - $14,354	-111 Reduced 0.81%	13,665 $1.51 Million
Q1 2019 Apr 09, 2019	BUY	$111.31 - $131.02 $16,585 - $19,521	149 Added 1.09%	13,776 $1.79 Million
Q4 2018 Mar 19, 2019	BUY	$105.9 - $118.64 $1.44 Million - $1.62 Million	13,627 New	13,627 $1.58 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Centric Wealth Management with notifications on news.

Account

Centric Wealth Management Eli Lilly & CO Transaction History